Vitamins In Cosmetics 2026: EU & UK Safety, Formulation, Claims And Compliance Guide

What Cosmetic Manufacturers Need to Know About Vitamin Selection, Stability, Safety Assessments and Claims

Vitamins are widely used in cosmetic products because of their association with skin conditioning, antioxidant protection, moisturization, hair care and other cosmetic benefits.

However, incorporating a vitamin into a cosmetic formulation is not simply a matter of selecting an ingredient with a recognized consumer benefit.

Many vitamins are chemically sensitive and can degrade when exposed to light, oxygen, heat, water or incompatible formulation conditions. Manufacturers may therefore use more stable derivatives, encapsulation technologies or protective packaging to maintain product quality throughout their intended shelf life.

At the same time, cosmetic products containing vitamins must comply with applicable European Union and United Kingdom cosmetic legislation, including requirements covering ingredient safety, product information, safety assessment, labelling and cosmetic claims.

This becomes particularly important for vitamins with established regulatory restrictions or exposure considerations.

For example, Vitamin A compounds such as retinol, retinyl acetate and retinyl palmitate are subject to specific restrictions in EU cosmetics, including concentration limits introduced through amendments to Annex III of Regulation (EC) No. 1223/2009.

Manufacturers therefore need to consider not only the concentration of a vitamin in an individual product, but also the broader regulatory framework, formulation stability, exposure and claims associated with the finished cosmetic.

Why Vitamins Are Important Cosmetic Ingredients

Vitamins can perform different functions in cosmetic formulations depending on their chemical form, concentration and intended application.

Common examples include:

• Vitamin A and its cosmetic derivatives
• Vitamin C and its derivatives
• Vitamin E and tocopherols
• Vitamin B3 (niacinamide)
• Vitamin B5 and panthenol
• Vitamin B7 (biotin)
• Vitamin B12
• Vitamin B6 derivatives

These ingredients can be incorporated into products such as:

• Facial creams
• Serums
• Lotions
• Cleansers
• Hair-care products
• Scalp products
• Anti-ageing cosmetics
• Skin-conditioning products
• Eye-area products
• Body-care products

However, the regulatory assessment depends on the specific substance, not simply the name of the vitamin.

A manufacturer should therefore identify the exact chemical form, concentration, function, formulation environment and intended cosmetic claim before determining compliance.

Vitamin Selection Requires More Than Ingredient Popularity

One of the first considerations should be whether the selected vitamin form is appropriate for the intended formulation.

Different forms of the same vitamin may have substantially different:

• Stability
• Solubility
• Oxidation sensitivity
• Compatibility
• Skin availability
• Regulatory status
• Recommended concentration
• Packaging requirements

For example, some vitamin forms can be highly sensitive to oxidation or light. A formulation may therefore require stabilization strategies or a derivative with improved formulation stability.

The objective should be to select a vitamin form that can deliver the intended cosmetic function while remaining stable, safe and legally supportable.

Stability and Protective Packaging

Vitamin stability is one of the most important formulation considerations.

Some vitamins can undergo degradation through exposure to environmental conditions. This can reduce the concentration of the active ingredient, change product appearance or generate degradation products that need to be considered in the safety and quality assessment.

Potential stability factors include:

• UV and visible light
• Oxygen
• Temperature
• Water activity
• pH
• Metal ions
• Oxidizing agents
• Reducing agents
• Interaction with other formulation components

Packaging can therefore become part of the formulation strategy.

Manufacturers may consider:

• Opaque containers
• Airless pumps
• Low-oxygen packaging
• UV-protective materials
• Appropriate closures
• Single-use packaging
• Controlled headspace

The packaging system should be selected based on the characteristics of the formulation and demonstrated through appropriate stability testing.

A vitamin formulation that is stable immediately after manufacture but significantly degrades during storage may not deliver the intended product characteristics throughout its marketed shelf life.

EU Cosmetic Regulatory Framework

In the European Union, cosmetic products are principally regulated under Regulation (EC) No. 1223/2009 on cosmetic products.

The framework establishes requirements covering areas including:

• Product safety
• Responsible Person
• Cosmetic Product Safety Report (CPSR)
• Product Information File (PIF)
• Ingredient restrictions
• Labelling
• Claims
• Good Manufacturing Practice
• CPNP notification
• Market surveillance

Vitamins are not automatically prohibited or restricted simply because they are vitamins.

However, specific vitamin substances may be subject to restrictions depending on their chemical identity and intended use.

Manufacturers should therefore check the relevant Annexes of the EU Cosmetics Regulation before selecting an ingredient and determining its concentration.

Vitamin A: A Key Regulatory Example

Vitamin A provides an important example of why vitamin-containing cosmetics require careful regulatory assessment.

The EU introduced restrictions on certain Vitamin A compounds through Commission Regulation (EU) 2024/996, which amended Annex III of Regulation (EC) No. 1223/2009.

The restrictions cover:

• Retinol
• Retinyl acetate
• Retinyl palmitate

For products that fall within the relevant categories, the regulation establishes maximum concentrations of 0.05% retinol equivalent (RE) for body lotion and 0.3% RE for other leave-on and rinse-off products.

Products containing these substances must also carry a specific warning concerning the presence of Vitamin A and the need to consider total daily intake from other sources.

The transition periods are also important: products not complying with the new requirements could no longer be placed on the EU market after 1 November 2025 and could no longer be made available on the EU market after 1 May 2027.

This demonstrates why manufacturers should not assess vitamin ingredients solely according to their concentration in a single formula.

Cumulative Exposure and Safety Assessment

A major regulatory consideration for certain vitamins is consumer exposure from multiple sources.

A consumer may obtain a particular vitamin from:

• Food
• Food supplements
• Medicines
• Cosmetics
• Multiple cosmetic products

For restricted vitamin substances, safety assessments therefore need to consider the relevant exposure scenario.

For Vitamin A, the regulatory concern is particularly important because excessive systemic exposure to certain forms of Vitamin A can present health risks.

Cosmetic manufacturers should therefore ensure that their safety assessment considers:

• Ingredient concentration
• Product category
• Amount applied
• Frequency of use
• Application site
• User population
• Dermal exposure
• Potential systemic exposure
• Use of multiple products where relevant

The Cosmetic Product Safety Report should therefore be based on the finished cosmetic product and foreseeable conditions of use, rather than simply relying on general ingredient safety information.

Vitamin C and Derivative Selection

Vitamin C illustrates a different formulation challenge.

Pure ascorbic acid can be sensitive to oxidation and may present formulation challenges involving stability, pH and packaging.

Cosmetic manufacturers may therefore use vitamin C derivatives designed to provide improved formulation stability.

Potential considerations include:

• Chemical stability
• Water or oil solubility
• pH requirements
• Oxidation resistance
• Compatibility
• Packaging
• Conversion or availability of the vitamin form
• Available safety information

The use of a derivative does not eliminate the need for regulatory assessment.

The exact substance must still be identified, its safety assessed and its cosmetic function substantiated appropriately.

Vitamin E and Other Common Vitamins

Vitamin E compounds, including tocopherols and tocopherol derivatives, are widely used in cosmetic formulations.

Depending on the specific substance, they may serve functions such as antioxidant support, skin conditioning or formulation protection.

Likewise, ingredients such as niacinamide and panthenol are widely incorporated into skin and hair-care products.

However, the same regulatory principle applies:

The fact that an ingredient is widely used does not automatically establish compliance for every formulation, concentration or claim.

Manufacturers should assess the specific ingredient and finish product against applicable EU and UK requirements.

Cosmetic Claims: Avoiding Medicinal Positioning

One of the most important regulatory risks associated with vitamin cosmetics is the wording used to market them.

A cosmetic product may communicate benefits relating to:

• Skin conditioning
• Appearance
• Hydration
• Smoothing
• Brightening
• Maintaining normal-looking skin
• Improving the appearance of signs of ageing

However, claims that suggest treatment or prevention of a disease or physiological disorder can create significant regulatory concerns.

Examples of higher-risk positioning may include statements suggesting that a cosmetic:

• Treats eczema
• Cures acne
• Prevents skin disease
• Heals dermatitis
• Treats psoriasis
• Reverse a medical condition

The distinction is not determined only by the ingredient.

The overall presentation of the product can be relevant, including advertising, website content, packaging, social media and consumer communications.

EU and UK Claims Compliance

The EU Cosmetics Regulation requires cosmetic claims to be truthful and supported by adequate evidence.

The Common Criteria for Cosmetic Claims establish principles relating to:

• Legal compliance
• Truthfulness
• Evidential support
• Honesty
• Fairness
• Informed decision-making

The UK has retained a similar regulatory framework following Brexit, although companies marketing cosmetics in Great Britain must consider UK-specific regulatory requirements and responsible-person arrangements.

Companies should therefore ensure that claims are reviewed as part of the overall product compliance strategy.

2026 Vitamin Cosmetic Compliance Checklist

Frequently Asked Questions

1. Are vitamins allowed in cosmetic products?

Many vitamins and vitamin derivatives can be used in cosmetics, subject to the applicable requirements for the specific substance, concentration, product type and market.

2. Why are vitamin derivatives used?

Derivatives may offer improved stability, solubility or formulation compatibility compared with parent vitamin, depending on the substance.

3. Why is packaging important for vitamin cosmetics?

Some vitamin ingredients can be sensitive to light, oxygen, heat or moisture. Appropriate packaging can help protect formulation stability throughout the intended shelf life.

4. Are Vitamin A ingredients restricted in EU cosmetics?

Yes. Certain Vitamin A compounds, including retinol, retinyl acetate and retinyl palmitate, are subject to restrictions under EU cosmetic legislation.

5. Can a vitamin cosmetic claim to treat skin condition?

Care is required. Claims suggesting treatment or prevention of a disease may move the product outside conventional cosmetic positioning and should be assessed carefully under the applicable regulatory framework.

6. Does ingredient safety information alone support a cosmetic product launch?

Not necessarily. The finished product requires an appropriate safety assessment, considering concentration, exposure, formulation, intended use and other relevant factors.

Conclusion

Vitamins can provide valuable cosmetic functions, but successful vitamin formulation requires much more than selecting a popular ingredient.

Manufacturers need to consider the chemical form, stability, concentration, exposure, packaging, toxicological profile and regulatory status of each vitamin or derivative.

The EU and UK regulatory environments also require careful control of cosmetic claims. Attention is necessary for substances such as Vitamin A, where restrictions and cumulative exposure considerations can significantly influence formulation and market strategy.

For manufacturers and brand owners, the most effective approach is to integrate formulation development, stability testing, safety assessment, packaging selection and claims substantiation from the beginning of product development.

As scientific scrutiny and cosmetic regulation continue to evolve, companies that build regulatory considerations into vitamin product development can better manage compliance risks while maintaining credible and substantiated consumer communication.

How Maven Regulatory Solutions Can Help

Maven Regulatory Solutions can support cosmetic companies with:

• EU cosmetic regulatory assessments
• UK cosmetic compliance assessments
• Vitamin ingredient regulatory reviews
• Cosmetic ingredient restriction assessments
• CPSR and safety assessment support
• Product formulation compliance reviews
• Vitamin A compliance assessments
• Cumulative exposure assessments
• Stability and packaging regulatory assessments
• Cosmetic claims substantiation
• Label and artwork compliance reviews
• EU CPNP and UK SCPN regulatory support
• PIF compliance assessments
• Market-entry strategy
• Regulatory intelligence and monitoring

Our approach helps cosmetic manufacturers and brand owners develop safe, compliant and scientifically substantiated vitamin-containing cosmetic products for the EU and UK markets.